Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

47893 Press Releases
DateTitleCompany
10 Feb 11 ProCertus BioPharm, Inc. Announces the Initiation of a Clinical Trial for the Prevention of Radiodermatitis in Post-Surgical Breast Cancer Patients ProCertus BioPharm Inc.,
Published by
Business Wire
10 Feb 11 Sorin: 2010 Preliminary Results: Strong Increase in Profitability and Further Significant Reduction in Net Debt Sorin S.p.A.,
Published by
Business Wire
10 Feb 11 BioAlliance Pharma: Consolidated Turnover for 2010 Exceptional Performance Linked to International Licensing Agreements BioAlliance Pharma,
Published by
Business Wire
10 Feb 11 GfK CEE invests in Tobii eye tracking to improve insight into consumer behaviour GfK CEE
10 Feb 11 Bon Secours Health System Inc. receives national award for excellence in delivering high quality, cost-effective care Premier,
Published by
Business Wire
10 Feb 11 GE Listed as National Patient Safety Organization by HHS, AHRQ GE Healthcare,
Published by
Business Wire
10 Feb 11 Bard Names Todd W. Garner Vice President, Investor Relations C. R. Bard Inc.,
Published by
Business Wire
10 Feb 11 Dr. Tellez Joins Biocodex USA as Principal, Business Development and Strategy Biocodex USA,
Published by
Business Wire
10 Feb 11 RegeneRx Receives Notice of Australian Patent to be Granted for the Use of TB4 to Prevent Scarring and Fibrosis RegeneRx Biopharmaceuticals Inc.,
Published by
Business Wire
10 Feb 11 Imaging Diagnostic Systems Installs CT laser Mammography system in Indonesia Imaging Diagnostic Systems Inc.,
Published by
Business Wire
10 Feb 11 BSD Medical Announces News Coverage Highlighting MicroThermX® Microwave Ablation System BSD Medical Corporation,
Published by
Business Wire
10 Feb 11 CEL-SCI Corporation Reports First Quarter 2011 Financial Results CEL-SCI Corporation,
Published by
Business Wire
10 Feb 11 BioMimetic Therapeutics, Inc. to Highlight Commercial and Product Development Activities during AAOS BioMimetic Therapeutics Inc.,
Published by
Business Wire
10 Feb 11 Phlexglobal launches dedicated career development training curriculum Phlexglobal,
Published by
BCS PR
10 Feb 11 Research and Markets: Gadobutrol - Key Patent, SPC and Data Exclusivity Expiry for 44 Countries Research and Markets,
Published by
Business Wire
10 Feb 11 Research and Markets: Aliskiren: Comprehensive Patent Search - Eliminate Unnecessary Risk Research and Markets,
Published by
Business Wire
10 Feb 11 ROTH Capital Initiates Equity Research Analyst Coverage on Biovest Biovest International Inc.,
Published by
Business Wire
10 Feb 11 Fluidigm Corporation Prices Initial Public Offering of Common Stock Fluidigm Corporation,
Published by
Business Wire
10 Feb 11 Intellikine and the PKD Foundation Collaborate to Advance Next-Generation Therapies for Polycystic Kidney Disease Intellikine,
Published by
Business Wire
10 Feb 11 Acorda Therapeutics to Host Conference Call to Report Fourth Quarter and Full Year 2010 Financial Results on February 17, 2011 Acorda Therapeutics Inc.,
Published by
Business Wire
10 Feb 11 Electromed, Inc. Reports 2011 Second Quarter Results Electromed Inc.,
Published by
Business Wire
10 Feb 11 Tetraphase to Present at the Leerink Swann Hot Topics in Therapeutics Roundtable Conference Tetraphase Pharmaceuticals Inc.,
Published by
Business Wire
10 Feb 11 Global ePRO Leader PHT Corporation Achieves Record-Breaking 2010 PHT Corporation,
Published by
Business Wire
10 Feb 11 Covidien Receives FDA Approval for Fentanyl Transdermal System Patch Covidien,
Published by
Business Wire
10 Feb 11 Anacor and Medicis Enter Into Research and Development Collaboration for the Treatment of Acne Anacor Pharmaceuticals Inc.,
Published by
Business Wire
10 Feb 11 Incyte Reports 2010 Financial Results; Provides 2011 Key Objectives and Financial Guidance Incyte Corporation,
Published by
Business Wire
10 Feb 11 Promedior Announces Publication of New Research Demonstrating Pentraxin-2/SAP is a Potent Inhibitor of Pulmonary Fibrosis Promedior Inc.,
Published by
Business Wire
10 Feb 11 Promedior Initiates Clinical Study of Anti-Fibrotic Therapeutic, PRM-151, in Patients with Idiopathic Pulmonary Fibrosis (IPF) Promedior Inc.,
Published by
Business Wire
10 Feb 11 Theragenics to Report Fourth Quarter and Year-End 2010 Financial Results Tuesday, February 15 Theragenics Corporation,
Published by
Business Wire
10 Feb 11 Curis Reports Fourth Quarter and Year-End 2010 Financial Results Curis,
Published by
Business Wire
Advertising